EP Patent

EP3976017A4 — PHARMACOLOGICAL AGENTS FOR THE TREATMENT OF PROTEIN AGGREGATE DISEASES OF THE EYE

Assigned to Plex Pharmaceuticals Inc · Expires 2023-06-14 · 3y expired

What this patent protects

Patent listed against acoramidis-hydrochloride.

Drugs covered by this patent

acoramidis-hydrochloride (ACORAMIDIS HYDROCHLORIDE)

Patent Metadata

Patent number: EP3976017A4
Jurisdiction: EP
Classification: —
Expires: 2023-06-14
Drug substance claim: No
Drug product claim: No
Assignee: Plex Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.